Literature DB >> 17550558

Clinical patterns of sexually transmitted diseases, associated sociodemographic characteristics, and sexual practices in the Farwaniya region of Kuwait.

Nawaf Al-Mutairi1, Arun Joshi, Osama Nour-Eldin, Ashok K Sharma, Ibtesam El-Adawy, Manish Rijhwani.   

Abstract

BACKGROUND: Sexually transmitted diseases (STDs) are common worldwide, but there are few studies available on STDs from the Gulf countries, including Kuwait. Our goal was to determine the clinical patterns, sociodemographic factors, and sexual practices of patients with STDs who attended a government hospital in the Farwaniya region of Kuwait.
METHODS: All patients seen over a 1-year period (July 2003 to June 2004), who presented with signs and symptoms suggestive of STDs, were included. Sociodemographic details and clinical findings were recorded. The diagnosis of each STD was based mainly on standard World Health Organization (WHO) criteria and available data. Serologic tests for syphilis and human immunodeficiency virus (HIV) were offered to all patients.
RESULTS: One thousand and ninety-six patients (1068 male, 28 female) with STDs constituted 2.84% of all new dermatology patients seen; most (866) were in the 21-40-year age group. The STDs were acquired from commercial sex workers in 844 patients (77%). Heterosexual encounter (99.3%) was the most common mode of acquiring STDs. Urethral discharge was noted in 54.1% of patients, followed by genital ulcers (17.8%), papules/growths (16.4%), and urethral/pubic pain without associated discharge/ulcers (5.9%); these were the four most common presenting complaints. Evaluation revealed gonorrhea in 31.5% of patients, nongonococcal urethritis in 23.6%, chlamydia in 4.1%, nonspecific urethritis in 19.5%, concomitant gonorrhea and chlamydia urethritis in 2.7%, genital warts in 13.7%, chancroid in 13.0%, genital herpes in 4.8%, molluscum contagiosum in 2.7%, and lymphogranuloma venereum in 1.4%.
CONCLUSIONS: Urethral discharge, gonorrhea, and nonspecific urethritis (presenting with urethral discharge), followed by genital warts, chancroid, and genital herpes (ulcers), were the most common STDs among male patients in the Farwaniya region of Kuwait. Although no case of HIV or syphilis was detected, health authorities and physicians need to remain vigilant.

Entities:  

Mesh:

Year:  2007        PMID: 17550558     DOI: 10.1111/j.1365-4632.2007.02843.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

1.  Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid.

Authors:  Isabelle Leduc; William G Fusco; Neelima Choudhary; Patty A Routh; Deborah M Cholon; Marcia M Hobbs; Glen W Almond; Paul E Orndorff; Christopher Elkins
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

2.  Screening of pregnant women attending the antenatal care clinic of a tertiary hospital in eastern Saudi Arabia for Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Authors:  Alhusain J Alzahrani; Obeid E Obeid; Manal I Hassan; Abdalaziz A Almulhim
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-07

3.  Sexually transmitted infections in Pakistan.

Authors:  Muhammad Arif Maan; Fatma Hussain; Javed Iqbal; Shahid Javed Akhtar
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

4.  HIV epidemiology among female sex workers and their clients in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions.

Authors:  Hiam Chemaitelly; Helen A Weiss; Clara Calvert; Manale Harfouche; Laith J Abu-Raddad
Journal:  BMC Med       Date:  2019-06-24       Impact factor: 8.775

5.  Disease Pattern among Sexually Transmitted Infection Clinic Attendees: A Hospital-Based Study.

Authors:  Krishna Talukdar; Ajay Chopra; Debdeep Mitra; Barnali Mitra
Journal:  Indian J Dermatol       Date:  2018 Nov-Dec       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.